Biocon chief Kiran Mazumdar-Shaw expresses concern over COVID-19 vaccine shortage

By: |
May 11, 2021 12:34 PM

Biocon Executive Chairman Kiran Mazumdar-Shaw has expressed concern over shortage of COVID-19 vaccines and sought better transparency from the government regarding their availability so that citizens could patiently wait for their turn.

Biocon chairman, Kiran Majumder Shaw, shortage of vaccine, transperency in availability of vaccine, Ministry of health and family welfareVery concerned about why vaccines are in such short supply, said Kiran Shaw in a tweet

Biocon Executive Chairman Kiran Mazumdar-Shaw has expressed concern over shortage of COVID-19 vaccines and sought better transparency from the government regarding their availability so that citizens could patiently wait for their turn. India has announced expansion of its COVID-19 vaccination drive by allowing its large population aged over 18 to get inoculated from May 1.

“Very concerned about why vaccines are in such short supply. Can we please know where the 70 million doses are being deployed every month? @MoHFW_INDIA We need better transparency to avoid the suspense. If a timetable of supplies is made public people can patiently wait their turn,” Mazumdar-Shaw said in a tweet on Tuesday while tagging the Health Ministry.

Earlier this month, while responding to media reports alleging that centre has not placed any fresh order for COVID-19 vaccines, the Health Ministry had noted that 100 per cent advance of Rs 1,732.50 crore has been released to the Serum Institute of India (SII) on April 28 for 11 crore doses of Covishield vaccine during May, June and July.

The ministry had also stated that against the last order of 10 crore doses for supplies of Covishield vaccine, 8.744 crore doses have been delivered till May 3. SII had endorsed the government statement and said it had received the orders. The Health Ministry had further noted that 100 per cent advance of Rs 787.50 crore was released on April 28 to Bharat Biotech India Ltd (BBIL) for five crore Covaxin doses during May, June and July.
Bharat Biotech Joint Managing Director Suchitra Ella confirmed in a tweet that the vaccine major has commenced direct supply of ‘Covaxin’ to 14 states, including Delhi and Maharashtra, with effect from May 1.
The Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to the states based on the allocations received by the central government, she had noted.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Kerala sees 12,708 new COVID-19 infections; total case tally surges past 28.55 lakh
2Covid Effect: Ayurveda immunity products demand spike in Delhi, Mumbai, Bangalore during 2nd wave
3Karnataka Unlock: Mysuru only district to be under curbs; health officials send samples for genome sequencing